2 Chapter 6: Understanding and Preparing Risk Factors Associated With AAV Gene TherapiesDec 22, 20256:45
4 Ch 4: Clinical Safety and Efficacy Observed in AAV Mediated Gene Therapy Programs in DMD, SMA, XLMTMDec 22, 20254:51
5 Ch 3: Mitigation Strategies to Address the Challenges in the Development of Gene Therapy ProgramsDec 22, 20255:40
